Central nervous system germinomas are characterized by a massive immune cell infiltrate. We systematically characterized these immune cells in 28 germinomas by immunophenotyping and image analysis. mRNA expression was analyzed by Nanostring technology and in situ RNA hybridization. Tumor infiltrating lymphocytes (TILs) were composed of 61.8% 6 3.1% (mean 6 SE) CD3-positive T cells, including 45.2% 6 3.5% of CD4-positive T-helper cells, 23.4% 6 1.5% of CD8-positive cytotoxic T cells, 5.5% 6 0.9% of FoxP3-positive regulatory T cells, and 11.9% 61.3% PD-1-positive TILs. B cells accounted for 35.8% 6 2.9% of TILs and plasma cells for 9.3% 6 1.6%. Tumor-associated macrophages consisted of clusters of activated PD-L1-positive macrophages and interspersed antiinflammatory macrophages expressing CD163. Germinoma cells did not express PD-L1. Expression of genes encoding immune cell markers and cytokines was high and comparable to mRNA levels in lymph node tissue. IFNG and IL10 mRNA was detected in subfractions of TILs and in PD-L1-positive macrophages. Taken together, the strong immune reaction observed in germinomas involves inflammatory as well as various suppressive mechanisms. Expression of PD-1 and PD-L1 and infiltration of cytotoxic T cells are biomarkers predictive of response to anti-PD-1/PD-L1 therapies, constituting a rationale for possible novel treatment approaches.
INTRODUCTION
Pure germinomas are the most frequent subtype of malignant intracranial germ cell tumors (iGCTs), which also include teratomas, embryonal carcinomas, yolk sac tumors, choriocarcinomas, and mixed iGCTs. They usually occur along the midline affecting the pineal gland or the suprasellar region, and in some cases, both (bifocal germinoma). Together, iGCTs account for 3%-5% of pediatric CNS tumors in Western countries while their incidence is 5-8-fold higher in East Asia (1, 2) . In general, germinomas are very sensitive to radio-and chemotherapy, resulting in a 5-year survival rate of >90% (3). However, multiple adverse effects, such as secondary neoplasms, seizures, and neuroendocrine deficiencies follow this therapy (4) , making further research with respect to targeted therapies desirable.
Germinomas share immunohistochemical and molecular genetic characteristics with seminomas of the testis and dysgerminomas of the ovary indicating a similar pathogenesis (5, 6) . Nevertheless, the cellular origin of germinomas is still controversial. One well-established idea is origin from primordial germ cells (PGCs), which migrate in the midline during development. This hypothesis is supported by studies revealing expression of genes related to embryonic stem cell pluripotency and differentiation, for example, c-Kit, Oct-3/4, and Nanog, as well as global hypomethylation of germinoma cells, which is the epigenetic hallmark of PGCs (7, 8) . An alternate hypothesis postulates that germinomas derive from a braincell progenitor by a Kit-driven mechanism (9) .
One very striking histological feature of germinomas is their massive immune cell infiltrate. For a time, there was a question whether these "small lymphoid-appearing cells" were indeed lymphocytes or small tumor cells instead, but this was settled by the demonstration of lymphoid markers on the "small cells" (10) . Tumor infiltrating lymphocytes (TILs) can be so numerous as to obscure the tumor cells; as a result, some germinomas have been misdiagnosed as inflammatory lesions such as hypophysitis (11) . In addition to TILs, the presence of macrophages or histiocytes in the tumor microenvironment has also been described (12) . However, little is known about the precise nature of these immune cells and the mechanisms that trigger this exceptionally strong immune reaction.
The type and extent of immune cell infiltrates were found highly correlated with survival in different types of cancers including colorectal carcinomas (13) . In germinomas, a high proliferative activity of the tumor cells and a good response to treatment with favorable outcomes is characteristic. This raises the opposing hypotheses whether the immune system suppresses or promotes tumor growth. The aim of our study, therefore, was to systematically characterize and quantify germinoma-infiltrating immune cells and to examine the possible activation of intrinsic or adaptive immune checkpoints. In particular, the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway has become an encouraging target for therapy in various cancers expressing PD-L1 on tumor or immune cells, such as melanoma, glioma, urothelial cancers, lung cancer, and gastrointestinal cancers (14) (15) (16) (17) .
MATERIALS AND METHODS

Tumor Specimens
The study includes 28 pure germinomas diagnosed according to the WHO classification of tumors of the central nervous system (18) using histological and immunohistochemical methods. Tumor specimens were obtained from the archives of the Institute of Neuropathology, University of Bonn Medical Center (Bonn, Germany), of the DGNN German Brain Tumor Reference Center (Bonn, Germany), and the German Paediatric Tumor Registry (Kiel, Germany).
Immunohistochemistry
Four-micrometer-thick serial sections were cut from representative formalin-fixed, paraffin-embedded (FFPE) material, deparaffinized in xylene and rehydrated in a degraded alcohol sequence. Immunohistochemistry for all antibodies was performed using standard protocols on the automated IHC staining system Benchmark XT (Roche/Ventana, Tucson, AZ). The following antibodies were used: CD3 (LN10, dilution 1:50, Leica, Germany), CD4 (SP35, Roche/Ventana), CD8 (C8, dilution 1:100, Dako, Glostrup, Denmark), CD20 
Quantification of TILs
After IHC, slides were digitized on a slide scanner (MIRAX Scan, Carl Zeiss Microscopy, Jena, Germany) and analyzed using the Definiens Tissue Studio 3.5.1 software (Definiens, Munich, Germany). Representative areas of each specimen were selected for analysis and only TILs were taken into account for analysis. The software was programmed for either cell surface or nuclear staining and thresholds were adjusted individually. After each run, accuracy was checked by evaluation of screenshots.
mRNA Quantification
RNA was isolated from FFPE material of 23 germinomas and 1 lymph node with help of the AllPrep DNA/RNA FFPE Kit (Qiagen, Venlo, The Netherlands). Expression of specific gene transcripts was quantified by Nanostring technology (Nanostring Technologies, Seattle, WA) using the nCounter Human Pan Cancer Immune Profiling Panel. Probes to detect the following gene transcripts specific for germ cell markers were added to the panel: ALPP, DDX4, NANOG, LIN28A, POU5F1 exon 1a, PRDM14, SOX17, SOX2, and the housekeeper gene ARF1.
mRNA In Situ Hybridization
Four-micrometer-thick serial sections of FFPE tumor samples were baked in a dry oven for 1 hour at 60 C, deparaffinized in xylene and rehydrated in 100% ethanol. Hybridization of mRNA was performed according to the RNAscope 2.5 Assay (Advanced Cell Diagnostics, Hayward, WI) by incubating slides with hydrogen peroxide for 10 minutes followed by boiling in target retrieval reagents provided for 15 minutes at 100 C on a hot plate. A hydrophobic barrier was created around each section using the Immedge hydrophobic barrier pen provided. Protease Plus treatment was carried out at 40 C for 30 minutes in a HybEZ hybridization oven (Advanced Cell Diagnostics) followed by incubation with specific probes targeting PD-L1, IL-10, and IFNG at 40 C for 2 hours. Six amplification steps were performed as described in the RNAscope 2.5 Assay and mRNA was detected using Fast Red. In situ hybridization of RNA was then followed by IHC as described above using antibodies mentioned above specific for PD-L1 and CD163.
RESULTS
Clinical Features
Our study included 28 patients with a median age of 18 years at the time of diagnosis, ranging from 9 to 40 years (Table) . Twenty-three patients were male (82.1%) and 5 were female (17.9%). All tumors analyzed were pure germinomas with immunohistological expression of c-Kit and Oct4, which are recognized diagnostic criteria for germinomas. They affected predominantly the region of the pineal gland (17 of 28 [60.7%]), followed by the suprasellar region (6/28 [21.4%]). One tumor was bifocal (3.6%), 3 (10.7%) were located in other regions of the brain (thalamus, infratentorial, ventricular), and for 1 case (3.6%) the information concerning the exact location was not available. Survival data were available for 9 cases and revealed that no patient had a metastasis, subsequent events or died.
Germinomas Are Characterized by T-Cell Infiltration and Features of T-Cell Exhaustion
Immunohistochemical analysis for expression of immune cell markers was performed on 28 tumor specimens and quantified using an image analysis work station (Definiens tissue studio 3.5.1). Figure 1 shows representative staining results for immunohistochemistry. All specimens showed high infiltration by CD45-positive TILs including 35.8% 6 2.9% CD20-positive B cells and 61.8% 6 3.1% CD3-positive T cells (Fig. 2) . Among the B cells, there was a noticeable fraction of 9.3% 6 1.6% Mum-1-positive plasma cells. To verify Mum-1 specificity for plasma cells, syndecan-1 was stained as an alternative plasma cell marker in 3 specimens and yielded consistent results (data not shown). T cells were composed of 45.2% 6 3.5% CD4-positive T-helper cells and 23.4% 6 1.5% CD8-positive cytotoxic T cells. CD4 staining was not restricted to lymphoid cells; it is also slightly expressed by macrophages. FoxP3-positive regulatory T cells accounted for 5.5% 6 0.9% and PD-1 was positive on 11.9% 61.3% of TILs indicating T-cell exhaustion (Fig. 2) . CD56-positive natural killer cells stained by NCAM-PSA antibodies were rare (results not shown).
PD-L1 Is Expressed Exclusively by Clusters of Activated Macrophages
A strong surface staining for PD-L1 was found in all examined germinoma samples; however not on tumor cells, but exclusively on tumor associated macrophages (TAMs) identified by CD68 (Fig. 1) . Comparing IHC staining patterns, PD-L1-positive clusters of macrophages were also positive for HLA-DR, indicating an activated immune state, whereas CD163-positive anti-inflammatory TAMs were observed as interspersed cells.
Transcriptional Profiling Reveals High mRNA Levels for Transcripts of PGC and Immune Cell Markers mRNA isolated from 23 germinoma samples and one lymph node was quantified by Nanostring technologies using barcoded probes specific for immune cell marker, cytokine, and PGC marker gene transcripts. Analysis of mRNA levels revealed high expression of PGC markers in germinomas relative to expression in the lymph node, especially of NANOG, POU5F1 exon 1, PRDM14, LIN28A, and PRAME (Fig. 3) . Expression of genes related to immune cell markers and cytokines was also high in germinomas and largely comparable to mRNA levels in lymph node tissue. Remarkably, transcription of some immune related genes in tumor tissue differed significantly from that in lymph node tissue. For example, mRNA levels of immune checkpoint molecule CD276, survivinencoding BIRC5, and F2RL1 were significantly overrepresented in germinomas relative to lymph node tissue, whereas levels of chemokines and dendritic cell specific gene transcripts, CD209, CXCL2, and CCL21, respectively, were substantially higher in lymph node tissue. Details of significantly differentially expressed gene transcripts are shown in Figure 3 .
RNA In Situ Hybridization of Potential Regulators of PD-L1 Expression-IFNG and IL-10
To gain insight into regulation of PD-L1 expression in germinomas, mRNA in situ hybridization with probes specific for mRNA transcripts of potentially involved cytokines (i.e. interferon c [INFG] and interleukin 10 [IL10]) was carried out. In 3 representative cases, in situ hybridization was combined with IHC using antibodies against PD-L1 and CD163 to examine cell type specific expression. PD-L1 mRNA was detected specifically in TAMs showing PD-L1 protein expression on the surface, whereby most of these cells did not express CD163 (Fig. 4) . IFNG mRNA was slightly expressed by some PD-L1-positive TAMs and stronger by individual TILs, however, not by CD163-positive TAMs. IL-10 mRNA was detected in PD-L1-positive as well as CD163-positive TAMs and in higher levels in individual TILs.
DISCUSSION
Phenotyping of Immune Cell Infiltrates in Germinomas Reveals Multiform Immune Reactions Involving Inflammatory and Immunosuppressive Mechanisms
The original hypothesis of cancer immunosurveillance by Burnet and Thomas proposing that adaptive immunity prevents oncogenesis has nowadays been transformed into the concept of cancer immunoediting (19) (20) (21) . This implies a dual role for the immune system both suppressing and promoting tumor growth and resulting in a complex interplay between immune and tumor cells (21) . Our study shows that the immune reaction in germinomas comprises the whole range of cell types characteristic for adaptive immunity and that both inflammatory and immunosuppressive mechanisms exist. Among lymphocytes, CD3-positive T cells dominated the tumor microenvironment, with T-helper cells outweighing cytotoxic T cells, considerable amounts of PD-1-positive cells (median 11.9%), and few regulatory T cells (median 5.5%). These results are consistent with studies in testicular germ cell tumors (TGCTs) where seminomas showed especially high T-cell infiltration and markers for T-cell exhaustion as PD-1 (22) .
However, the number of B cells including plasma cells in germinomas was remarkable as well and varied among specimens, in some cases equaling numbers of T cells. The prominent B cell/plasma cell fraction suggests that in germinomas, a humoral response may represent a dominant immune component besides cellular T-cell driven mechanisms. The heterogeneity within the studied cohort may be due to differences in specific triggering factors not yet identified.
Infiltration of lymphocytes has been correlated with prognosis in a great number of tumor entities, with differing results. Analysis of brain metastases, for instance, revealed no significant association of patient survival with TILs (23), whereas in melanomas higher T-cell content leads to improved survival (24, 25) . In TGCTs, high T-cell infiltration, decreased Treg cell infiltration, and higher PD-1/PD-L1 interaction are associated with good prognosis and seminoma histology (22) . In colorectal cancers, the type, density, and location of TILs as defined in a colorectal cancer "immunoscore" have been shown to be of even superior prognostic value than TNM classification (13) . Taking the favorable prognosis of germinoma patients in comparison to other types of iGCTs into account, it would be worthwhile to compare immune infiltration in these entities and show if differences according to those demonstrated in seminomas versus nonseminomas exist. A definitive statement about association of TILs to prognosis in germinomas cannot be made from our data because in this cohort too few events after appropriate treatment occurred.
As TAMs are known to be key players in cancer-related immune infiltration (26, 27) , another focus of our study was to analyze the subtypes of TAMs present in the tumor microenvironment and uncover some of their interactions with TILs and tumor cells. TAMs show high plasticity, both responding to and shaping the tumor microenvironment (28) . Although the strict paradigm of activated M1 versus inhibitory M2 polarized macrophages has been challenged by recent single cell analyses, different subsets of TAMs still seem to reflect the diversity of their inflammatory and immunosuppressive functions (29) . In germinomas, we ubiquitously detected clusters of activated macrophages, which co-expressed HLA-DR and PD-L1. These clusters were spatially separated from antiinflammatory CD163-positive interspersed TAMs matching the immunosuppressive M2 type.
The coexistence of both inflammation and immunosuppression was also found at the cytokine level with mRNA expression of proinflammatory IFNG and anti-inflammatory IL-10 in subsets of TILs and TAMs. In addition to activated TILs, we detected considerable numbers of FoxP3-positive Tregs and PD-1-positive TILs representing inhibitory mechanisms. Taken together, our data show that the immune reaction in germinomas reflects the whole complexity of interactions between the immune system and tumor cells, whereby immunoediting could lead to tolerance of cancer cells and so called "tumor escape" (30) .
Possible Triggering Mechanisms of Extensive Immune Infiltration
Regarding the reasons for extensive immune infiltration, chemotactic and triggering mechanisms in germinomas remain unclear. For other cancer types with high immune infiltration such as melanomas, lung cancer, gastric cancer, and colorectal carcinomas with microsatellite instability, generation of immunogenic neoantigens by high mutational load has been suggested as trigger (13) . In germinomas, chromosomal instability could function in a similar way (8) . However, the germ cell character of germinomas allows an alternative hypothesis: Oncofetal antigens naturally expressed by PGCs could be detected as foreign, especially in the immune privileged area of the brain. MAGE genes and PRAME, for example, both highly transcribed in germinomas (Fig. 3) , have been shown to code for antigens targeted by cytolytic T cells (31, 32) . In particular, we found MAGEB2 transcripts highly overrepresented in germinomas. Notably, these transcripts were also identified to be highly expressed in seminomas when compared with nonseminomatous TGCTs (22) .
TPTE transcripts were found highly overrepresented in germinomas. TPTE encodes a transmembrane phosphatase with tensin homology (33) . It is known to be highly expressed in testis tissue but its exact function has not been elucidated. In this respect, the identification of the specific substrates of this phosphatase and its possible function in signaling pathways will be of high interest.
To gain further information regarding the germinomaspecific immune reaction, identification of the specificity of infiltrative T cells and antibodies produced by plasma cells should be performed.
In addition to triggering mechanisms, identification of resistance factors against immune attack is essential as it could provide new targets for immune therapy. Germinomas are highly proliferative tumors and TILs obviously fail to eliminate the tumor cells suggesting the presence of anti-inflammatory or defense mechanisms. In this respect, quantification of mRNA by Nanostring technologies uncovered a range of candidates for further analysis. CD276 (B7-H3), for example, which in our study was highly expressed in germinoma tissue, has been shown to regulate T-cell responses both in stimulatory and inhibitory manner and can be detected on either immune cells or cancer cells. Nevertheless, no receptors for CD276 are known and protein expression seems to be regulated mostly posttranscriptionally (34) . Further studies should therefore include immunohistological examination of CD276 protein expression to identify the cellular source of this immunoregulatory protein.
Another overrepresented gene transcript found in germinomas was BIRC5, encoding survivin. This protein is expressed in various cancer types and has been described as inhibitor of Fas-mediated apoptosis in colorectal cancer specifically suppressing immune attack (35, 36) . To obtain clues regarding cell-specific expression and signaling of this and other transcripts involved in immune interactions in the tumor microenvironment, single cell RNA sequencing, in situ hybridization or high plex multi-analyte profiling by Nanostring, providing high spatial resolution, might be considered.
PD-L1 and PD-1 Expression in Germinomas Could Be Mediated by Adaptive Immune Resistance and Bears a New Target for Therapy
Immune checkpoints naturally controlling immune homeostasis have become a constant focus in cancer research in the last years because in multiple tumor entities they seem to be induced to evade immune attack. In this regard, especially the PD-L1/PD-1 checkpoint has emerged as a promising target for anticancer immune therapy (37) . In contrast to PD-L1 expression on tumor cells as described in PTEN mutated gliomas and in melanomas (38, 39), we found PD-L1 expression in germinomas entirely restricted to a fraction of HLA-DR-positive and CD163-negative macrophages. Previous studies on PD-L1 expression in TGCTs yielded heterogenous results. Fankhauser et al found PD-L1 expression to be more prominent in seminomas versus nonseminomatous gonadal germ cell tumors, however, with predominant expression in nonneoplastic, stromal cells (40). Cierna et al detected PD-L1 expression on tumor cells of all TGCT entities with higher levels in nonseminomas and correlation to poor prognosis (41) . We also performed IHC on germinomas with the PD-L1 antibody first used by Cierna et al (Abcam [EPR1161(2)]) and found tumor cells to be immunoreactive (not shown). However, this antibody was later retracted because binding to non-PD-L1 epitopes was identified. In our study, we therefore studied the cellular source of PD-L1 expression both by immunohistochemistry with a specific PD-L1 antibody and by mRNA in situ hybridization. PD-L1 mRNA expression was restricted to TAMs and perfectly matched IHC surface staining of the protein (Fig. 4) . Analogous to the concept of adaptive immune resistance (39), PD-L1 could be upregulated on TAMs by release of interferon gamma. By using combined in situ hybridization and immunohistochemistry, we detected IFNG to be transcribed in TILs and subsets of TAMs. IFNG is a known regulator of PD-L1 expression (42) . In this manner, it functions as a negative feedback loop, also upregulating PD-1 expression on TILs and promoting Treg invasion and production of anti-inflammatory cytokines such as IL-10 (37). IL-10 itself has been described as mediator of PD-L1 expression (43) and might further amplify this downregulation of inflammation in both autocrine and paracrine fashion. The expression of PD-L1 in correlation to prognosis has been examined in a variety of tumors resulting in contradictory results. In breast cancer, in situ mRNA expression of PD-L1 was associated with increased TILs and in head and neck cancer specifically the expression on immune cells lead to a significantly better prognosis (44, 45) . In renal cell carcinomas on the other hand, PD-L1 is associated with poor prognosis (16) . Regardless of this controversy, PD-L1, PD-1, and TIL infiltration as well as mutational status as for example mismatch repair deficiency have been recognized as biomarkers predictive for response to anti-PD-L1 and anti-PD-1 therapy (37, 46, 47) . Recent studies indicate that especially adaptive immune resistance and PD-L1 expression on immune cells are correlates of good response to anti-PD-1 and anti-PD-L1 antibodies (48, 49) . Therefore, immune checkpoint therapy emerges as a promising approach in germinomas, which contain these biomarkers.
